leadf
logo-loader
viewDelic Corp

Delic co-founder explains impending strategy of acquiring ketamine-focused psychedelic companies

Delic Holdings Corp (CSE:DELC) Co-founder Matt Stang tells Proactive the California-based psychedelic wellness corporation is looking to acquire revenue-positive companies in the psychedelic space, with a focus on ketamine.

Stang says the group will look to build out a framework of clinics that can dispense ketamine, as well as an entry-point to offer patients other novel compounds as the FDA grants permission for their use.

Quick facts: Delic Corp

Price: 0.56 CAD

CSE:DELC
Market: CSE
Market Cap: $21.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Mountain Valley MD files a patent for dosed adjuvant with potential...

Mountain Valley MD (CSE: MVMD) Director of Life Sciences Mike Farber joined Steve Darling from Proactive with news the company has applied for a patent to cover a novel dose sparing adjuvant with a potential application for Polio IPV delivery and the broader category of vaccines. Farber gives...

8 minutes ago

2 min read